Medical device maker ResMed (NYSE: RMD) is moving deeper into the Home Health & Hospice arena. The company announced its acquisition of HealthCareFirst, which provides software solutions for home health and hospice agencies.
HealthCareFirst offers electronic health record (EHR) software, billing and coding services, and advanced analytics to help agencies optimize their clinical, financial and administrative processes. Financial terms were not disclosed.
Pamlico Capital is the seller, having acquired HealthCareFirst in September 2012 from The Riverside Company.
ResMed’s devices and software solutions help to treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions.
In 2016, ResMed acquired Brightree, a portfolio company of Battery Ventures, for $800 million. Brightree provides cloud-based software-as-a-service business that helps improve clinical and business performance in the post-acute care segments of the home medical equipment (HME) market. The sectors it serves all have high prevalence of sleep-disordered breathing, COPD, neuromuscular disease and other chronic diseases.
The move is part of ResMed’s “connected health strategy,” using the data collected from its respiratory and sleep devices to deliver actionable information to custormers and patients. The company recently announced a new patient engagement app called MyAir, connected to its Air10 devices, on Android as well as iOS devices.
